2018 Guide to Effective Proxies

2.8 Election of directors | 127 6 TH EDITION | GUIDE TO EFFECTIVE PROXIES ENTERGY CORPORATION BOARDOFDIRECTORS Our 2018 Director Nominees The following pages contain information concerning each of the nominees for director, including each nominee’s age as of December 31, 2017, period served as a director, position (if any) with the Company, business experience and qualifications, directorships of other publicly-owned corporations (if any) andother professionalaffiliations. JohnR. Burbank Fairfield,Connecticut Age54 DirectorSince2018 EntergyBoardCommittees + + Mr. Burbank was elected to the Board effective March 2, 2018. If he is reelected, Mr. Burbank will be assigned to Board committees at the Board’s organizational meeting immediately following the Annual Meeting. ProfessionalExperience ‰ President,CorporateDevelopmentandStrategy, NielsenHoldingsplcsince2017(aglobal information,dataandmeasurementcompany) ‰ President,StrategicInitiatives,NielsenHoldings plc–2011-2017 ‰ DirectorofChangeLabs,LTD ‰ AdvisoryBoardMember,QuinnipiacUniversity SchoolofCommunication ‰ Trustee,MarchofDimes SkillsandAttributes Mr. Burbank brings to the Board his extensive management experience in consumer-facing businesses that have been and continue to be disrupted by technological change. Accordingly, he will bring valuable insights and perspective on the potential impact of technological change on our industry and our company. Mr. Burbank also brings the benefit of his extensive senior management experience leading strategic investments and corporate development and strategy at Nielsen Holdingsplc. Patrick J. Condon Frankfort,Illinois Age68 DirectorSince2015 EntergyBoardCommittees ‰ Audit(Chair) ‰ Nuclear ProfessionalExperience ‰ RetiredAuditPartnerofDeloitte&ToucheLLP (internationalpublicaccountingfirm)–2002-2011 ‰ FormerAuditPartnerofArthurAndersenLLP (internationalpublicaccountingfirm) ‰ FormerDirectorofCloudPeakEnergy,Inc.and Roundy’s,Inc. SkillsandAttributes As a retired audit partner of a “Big Four” accounting firm, Mr. Condon brings his many years of experience in auditing and accounting to the Board. As lead of Arthur Andersen’s utility group, Mr. Condon acquired in-depth knowledge of the utility industry. The Board alsobenefitsfromhisregionalandnationalleadership experience gained at Deloitte & Touche LLP and his current and prior service to community and charitable organizationsandonotherpubliccompanyboards. 2018ProxyStatement Š 13 Total of 05 pages in section EXELIXIS, INC. Class I Director Nominees forElectionforaThree-YearTermExpiringatthe2021AnnualMeeting Charles Cohen, Ph.D. ChiefExecutiveOfficer,PerformBiologics,Inc. Directorsince1995 Age67 KeyQualificationsandExpertise: OurBoardhasconcludedthatDr.Cohenshould continuetoserveasadirectorofExelixisasofthe dateofthisProxyStatementduetohistrainingasa scientist,hisknowledgeandexperiencewith respecttothebiotechnology,pharmaceuticaland healthcareindustries,hisbroadleadership experienceresultingfromserviceonvariousboards andasachiefexecutiveofficer,andhisknowledge andexperiencewithrespecttofinancematters. CharlesCohen,Ph.D.,hasbeenadirectorsinceNovember1995.Dr.Cohenisanindependent investorandsinceMarch2015,hasservedasChiefExecutiveOfficerandasamemberofthe boardofdirectorsofPerformBiologics,Inc.,aprivatebiotechnologystart-upcompany.Previously, Dr.CohenservedasChiefExecutiveOfficerandasamemberoftheboardofdirectorsofOn TargetTherapeutics,LLC,aprivatebiotechnologystart-upcompany,fromJune2015toJune2017. FromMay2007toDecember2015,Dr.CohenwasamanagingdirectorofSynthesisCapital (formerlyAdventHealthcareVentures),aventurecapitalfirm.From2003to2007,Dr.Cohenwas VicePresidentofAdventInternational,aglobalprivateequityfirm.From2000to2002,Dr.Cohen wastheChiefExecutiveOfficerofCellzomeAG,apost-genomicsbiotechnologycompany.Priorto thattime,Dr.Cohenco-foundedCreativeBioMolecules,Inc.,abiotechnologycompany,in1982 andwasoneofitsdirectorsanditsChiefExecutiveOfficerfrom1985to1995.Dr.Cohenservedas amemberoftheboardofdirectorsofthefollowingpublicly-heldcompanies:Anadys Pharmaceuticals,Inc.,abiopharmaceuticalcompanydedicatedtoimprovingpatientcareby developingnovelmedicinesforthetreatmentofhepatitisC,from2000to2005;andAnesiva,Inc., abiopharmaceuticalcompanyfocusedonthedevelopmentandcommercializationofnovel pharmaceuticalproductsforpainmanagementfrom2005to2007.Dr.Cohenalsoservedasthe ChairmanoftheSupervisoryBoardofCellzomeAG,priortoitsacquisitionbyGlaxoSmithKlinein May2012,andastheChiefExecutiveOfficerofseveralothercompanies.Dr.Cohenreceivedhis Ph.D.fromNewYorkUniversitySchoolofMedicine. George Poste, DVM, Ph.D., FRS ChiefScientist,ComplexAdaptiveSystemsInitiative Directorsince2004 Age73 KeyQualificationsandExpertise: OurBoardhasconcludedthatDr.Posteshould continuetoserveasadirectorofExelixisasofthe dateofthisProxyStatementduetohistrainingasa scientist,hisknowledgeandexperiencewith respecttothelifesciences,healthcareand pharmaceuticalindustries,hisbroadleadership experienceresultingfromserviceonvarious boards,andhisknowledgeandexperiencewith policymaking,regulatoryissuesandother governmentalmatters. GeorgePoste,DVM,Ph.D.,FRS,hasbeenadirectorsinceAugust2004.SinceFebruary2009, Dr.PostehasbeentheChiefScientistatComplexAdaptiveSystemsInitiativeandRegents’ ProfessorandDelE.WebbProfessorofHealthInnovationatArizonaStateUniversity.FromMay 2003toFebruary2009,Dr.PosteservedasthedirectoroftheBiodesignInstituteatArizonaState University.Dr.PostehasservedastheChiefExecutiveOfficerofHealthTechnologyNetworks,a consultingcompanythatspecializesintheapplicationofgenomictechnologiesandcomputingin healthcare,since2000.From1992to1999,hewastheChiefScienceandTechnologyOfficerand President,R&D,ofSmithKlineBeechamCorporation,apharmaceuticalcompany.Dr.Posteserved ontheDefenseScienceBoardoftheU.S.DepartmentofDefensefrom2001to2010andisa memberofotherorganizationsdedicatedtoadvancingdefensesagainstbioweaponsand biowarfare.Dr.PostehasservedasamemberoftheboardofdirectorsofMonsantoCompany,a publicly-heldproviderofagriculturalproductsandsolutions,since2003,andasamemberofthe boardofdirectorsofCarisLifeSciences,aprivately-heldmedicaldiagnosticscompany,since2009. FromApril2000untilAugust2009,Dr.PosteservedastheNon-ExecutiveChairmanofOrchid Cellmark,Inc.,apublicly-heldDNAforensicscompany.Dr.PosteisaFellowoftheRoyalSociety, theUKAcademyofMedicalSciences,HooverInstitution,StanfordUniversity,andvariousother prestigiousorganizationsandhasbeenawardedhonorarydoctoratesfromseveraluniversities. Dr.PosteholdsaD.V.M.inveterinarymedicineandaPh.D.inVirologyfromtheUniversityof Bristol,England. 8 Exelixis,Inc. Total of 06 pages in section EXXON MOBIL CORPORATION Item1–ElectionofDirectors TheBoardofDirectorshasnominatedthedirectorcandidatesnamedonthefollowingpages.Personalinformation oneachofournominees,includingpubliccompanydirectorshipsduringthepastfiveyears,isprovided.Alsoincluded aretheparticularexperiences,qualifications,attributes,andskillsofeachdirectornomineethatledtheBoardto concludethatsuchpersonshouldserveasadirectoroftheCompany. Allofournomineescurrentlyserveas ExxonMobildirectors. Alldirectornomineeshavestatedtheyarewillingtoserveifelected.Ifanomineebecomesunavailablebeforethe election,yourproxyauthorizesthepeoplenamedasproxiestovoteforareplacementnomineeiftheBoardnames one.Alternatively,theBoardmayreduceitssizetoequalthenumberofremainingnominees. TheBoardrecommendsyouvoteFOReachofthefollowingcandidates: Susan K. Avery Principaloccupation: PresidentEmeritaofthe WoodsHoleOceanographic Institution Age68 Directorsince2017 Independentdirector Committees: BoardAffairs,PublicIssues andContributions Experience,qualifications,andattributes: ‰ Globalleadership attheWoodsHoleOceanographicInstitution,aglobal researchorganization,asPresidentandDirectorfrom2008to2015 ‰ Academicleadership attheUniversityofColoradoBoulderasinterimdeanof thegraduateschoolandvicechancellorforresearch,interimprovost,and executivevicechancellorforacademicaffairsfrom2004to2008 ‰ Government/scientificresearch experienceasmemberoftheScientific AdvisoryBoardoftheUnitedNationsSecretary-Generalandmemberofthe NationalResearchCouncilGlobalChangeResearchProgramAdvisory Committee ‰ Scientificandresearch advisorycommitteemembershipsatNASA,NOAA, NationalScienceFoundation,NationalParkSystem,ClimateChangeScience Program,CenterforSouthernHemisphereOceanResearch,QingdaoNational LaboratoryforMarineScienceandTechnology,andJapanAgencyforMarine- EarthScienceandTechnology ‰ Scientificandenvironmentalaffiliations: ConsortiumforOceanLeadership (seniorfellow),AmericanGeophysicalUnion,AmericanMeteorologicalSociety (fellow),AmericanAssociationfortheAdvancementofScience(fellow),and InstituteofElectricalandElectronicsEngineers Currentpubliccompanydirectorships: None Previouspubliccompanydirectorshipsinlastfiveyears: None 2018ProxyStatement 15 Total of 06 pages in section FORTIVE CORPORATION Proposal1.ElectionofDirectors ClassIIDirectorNominees–Three-YearTermsThatWillExpirein2021 FerozDewan Directorsince: 2016 OtherCurrentPublicCompanyDirectorships: TheKraftHeinzCompany Age: 41 Independent FerozDewanhasservedastheChiefExecutiveOfficerofArenaHoldingsManagementLLC,aninvestmentholding company,since2016.Previously,Mr.DewanservedinaseriesofpositionswithTigerGlobalManagement,an investmentfirmwithapproximately$20billionundermanagementacrosspublicandprivateequityfunds,from2003 to2015,includingmostrecentlyasHeadofPublicEquities.HealsoservedasaPrivateEquityAssociateatSilverLake Partners,aprivateequityfirmfocusedonleveragedbuyoutandgrowthcapitalinvestmentsintechnology, technology-enabledandrelatedindustries,from2002to2003. Qualifications: Mr.Dewan’squalificationstositontheBoardinclude,amongotherfactors,extensiveexperiencein thetechnologyindustriesandtechnology-relatedcompanies,includingextensiveexperienceinvaluation, investmentsandacquisitions,financialreporting,riskmanagement,corporategovernance,capitalallocation, andoperationaloversight. JamesA.Lico Directorsince: 2016 OtherCurrentPublicCompanyDirectorships: NetScoutSystems,Inc. Age: 52 JamesA.LicohasservedastheChiefExecutiveOfficerandPresidentofFortivesincetheSeparationin2016.From 1996to2016,Mr.LicoservedinvariousleadershippositionsatDanaherCorporation,aglobalscienceand technologycompany,includingasExecutiveVicePresidentfrom2005to2016. Qualifications: Mr.Lico’squalificationstositontheBoardinclude,amongotherfactors,over20yearsofextensive experienceinseniorleadershippositions,includingasanExecutiveVicePresidentofDanaherwithoversightat varioustimesofeachofthebusinessesthatwasseparatedfromDanaherintoFortive.Mr.Lico,throughhisvarious seniorleadershippositionsatDanaherandFortive,hasbroadoperatingandfunctionalexperiencewith,anddeep knowledgeof,Fortive’sbusinesses,theFortiveBusinessSystem,capitalallocationstrategies,acquisitions,marketing andbranding,andleadershipstrategies. TheBoardofDirectorsrecommends thatshareholdersvote “FOR” theelection totheBoardofeachoftheforegoing ClassIIDirectorNominees. 2018ProxyStatement 15 Total of 03 pages in section